Reduction of Blood Lipids: A New Era for Cardiovascular Probiotics, Upcoming Webinar Hosted by Xtalks
Share Article
In this free webinar, the featured speaker will outline the unique hypolipidemic attributes of specific, clinically tested KABP probiotic strains. Also, the speaker will cover published experimental and clinical data demonstrating lipid reductions and mechanisms of action.
Cardio Probiotic reduces endogenous and exogenous cholesterol and increases triglyceride expenditure through multiple mechanisms of action. TORONTO (PRWEB) April 07, 2021 Dietary supplements for cholesterol/lipid reduction have long utilized a core group of familiar nutrients including Sterols, Omega 3s, Tocotrienols, Soluble Fibers, Pantethine and Polymethoxylated Flavonoids. Today, there is yet another potent option for the reduction of lipids and improvement in cardiovascular health: a multi-strain, Lactobacillus plantarum KAB